15. Biological Longevity Enhancement

Advancements in understanding aging pathways have spurred the development of drugs and gene therapies aimed at halting, slowing, or even reversing aging processes. Clinical trials are underway for senolytics—compounds that target and eliminate senescent cells—and for telomere manipulation techniques. These interventions hold the potential to extend healthspan and redefine societal age structures. For a comprehensive overview of these developments, refer to the article “Anti-Aging Drugs Could Be Coming. Are We Ready for Them?” published by Science. (science.org)